Recent Posts
- AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists
- AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
- AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
- AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
- AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ’25” On-Demand Conference
Recent Comments
No comments to show.